Stock Taper
LITS
LITE STRATEGY, INC.
NASDAQ
$0.98
▼ DOWN 1.96% (-0.02)

KEY STATISTICS

Market Cap$33.36 M
52w High$5.15
52w Low$0.69
Dividend Yield38.63%
FrequencySpecial
P/E-0.49
Volume103.00K
Shares Out.34.03M

COMPANY

LEADERSHIP

Justin J. File
CHIEF EXECUTIVE
Justin J. File

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 18, 2003
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
4

UPCOMING EARNINGS

DateSep 28, 2026
DayMonday
Rev. Est.$5.41M
SEP
28
MON

PRICE

$0.98 ▼ DOWN 1.96% (−$0.02)
$0.97$0.99$1.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.98

About Lite Strategy, Inc.

https://www.litestrategy.com ↗

Lite Strategy, Inc., formerly MEI Pharma, is a San Diego-based clinical-stage pharmaceutical company developing innovative cancer therapies since 2000.

INDUSTRY

Biotechnology

A SERVICE LITE STRATEGY, INC. IS KNOWN FOR

Litecoin Treasury Strategy

Lite Strategy, Inc. (LITS), formerly MEI Pharma, is the first U.S. publicly traded company to hold Litecoin as its primary treasury reserve asset, providing investors institutional-grade exposure to digital assets through its stock.

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

DIRECTOR
Flynn James P
Purchase · 25.0K shares
2026-06-24
DIRECTOR, OFFICER: CEO, CFO AND SECRETARY
File Justin J.
Purchase · 455.0K shares
2026-02-12
DIRECTOR
Flynn James P
Purchase · 70.0K shares
2025-12-19
10 PERCENT OWNER
Schornstein Alexander
Sale · 690.6K shares
2025-12-18

SECTORS PEERS

PEERPRICE
RLMD$4.33COMPARE
IMUX$15.40COMPARE
ACRV$2.06COMPARE
ACET$9.06COMPARE
XBIT$2.27COMPARE
PMVP$1.22COMPARE
NTRB$4.46COMPARE
TCRX$0.75COMPARE